Cerus Q3 revenue up 19% to $60.2M, raises FY2025 product revenue guidance

CERUS CORP

2025-Q3 EPS reported -$0.07

Product revenue $52.7M (+15% YoY); total revenue $60.2M (+19% YoY).
GAAP net loss narrowed to $0.02M (near breakeven); non-GAAP adjusted EBITDA $5.0M.
U.S. IFC sales $3.9M, volumes up ~110% YoY; hospital demand increasing.
Full-year 2025 product revenue guidance raised to $202-204M (prev. $200-203M).
Cash and investments $78.5M; generated $1.9M operating cash flow in Q3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.